Boston Scientific has appointed board members from Starbucks and Takeda Pharmaceuticals amidst a significant $14.5 billion acquisition spree. This move by one of Massachusetts’ largest companies brings in high-profile executives from diverse multinational corporations to its leadership.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Boston Scientific adds Starbucks CFO, Takeda CEO to board amid $14.5B buying spree
Boston Scientific has appointed board members from Starbucks and Takeda Pharmaceuticals amidst a significant $14.5 billion acquisition spree. This move by one of Massachusetts’ largest companies brings in high-profile executives from diverse multinational corporations to its leadership.